Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Nissan Chemical discloses novel cardiovascular agents

Jan. 2, 1997

FDA clears angiotensin II blocker from Ciba

Dec. 31, 1996

Combination antihypertensive product cleared by FDA

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Protein tyrosine kinase inhibitors from Warner-Lambert

Dec. 31, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Hyal products for restenosis receive U.S. patent coverage

Dec. 24, 1996

Intercardia and Knoll reach agreement for CHF drug

Dec. 24, 1996

Genzyme commences cardiovascular gene therapy collaboration

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...